These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

972 related articles for article (PubMed ID: 7595214)

  • 21. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.
    Nardin EH; Calvo-Calle JM; Oliveira GA; Nussenzweig RS; Schneider M; Tiercy JM; Loutan L; Hochstrasser D; Rose K
    J Immunol; 2001 Jan; 166(1):481-9. PubMed ID: 11123327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED; Corradin G; Hoffman SL
    J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria.
    Aidoo M; Lalvani A; Allsopp CE; Plebanski M; Meisner SJ; Krausa P; Browning M; Morris-Jones S; Gotch F; Fidock DA
    Lancet; 1995 Apr; 345(8956):1003-7. PubMed ID: 7536870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein.
    Moreno A; Clavijo P; Edelman R; Davis J; Sztein M; Sinigaglia F; Nardin E
    J Immunol; 1993 Jul; 151(1):489-99. PubMed ID: 7686946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant.
    Malik A; Gross M; Ulrich T; Hoffman SL
    Infect Immun; 1993 Dec; 61(12):5062-6. PubMed ID: 8225583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa.
    Plebanski M; Aidoo M; Whittle HC; Hill AV
    J Immunol; 1997 Mar; 158(6):2849-55. PubMed ID: 9058821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes.
    Hoffman SL; Weiss W; Mellouk S; Sedegah M
    Immunol Lett; 1990 Aug; 25(1-3):33-8. PubMed ID: 2283160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
    Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M
    Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants.
    Doolan DL; Khamboonruang C; Beck HP; Houghten RA; Good MF
    Int Immunol; 1993 Jan; 5(1):37-46. PubMed ID: 7680226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1.
    Schwenk R; Banania G; Epstein J; Kim Y; Peters B; Belmonte M; Ganeshan H; Huang J; Reyes S; Stryhn A; Ockenhouse CF; Buus S; Richie TL; Sedegah M
    Malar J; 2013 Oct; 12():376. PubMed ID: 24168370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Plasmodium falciparum sporozoite surface protein 2.
    Rogers WO; Malik A; Mellouk S; Nakamura K; Rogers MD; Szarfman A; Gordon DM; Nussler AK; Aikawa M; Hoffman SL
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9176-80. PubMed ID: 1409621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria.
    Arévalo-Herrera M; Valencia AZ; Vergara J; Bonelo A; Fleischhauer K; González JM; Restrepo JC; López JA; Valmori D; Corradin G; Herrera S
    Parasite Immunol; 2002 Mar; 24(3):161-9. PubMed ID: 12078650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum.
    Kumar S; Miller LH; Quakyi IA; Keister DB; Houghten RA; Maloy WL; Moss B; Berzofsky JA; Good MF
    Nature; 1988 Jul; 334(6179):258-60. PubMed ID: 2456467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum.
    Lalvani A; Aidoo M; Allsopp CE; Plebanski M; Whittle HC; Hill AV
    Res Immunol; 1994; 145(6):461-8. PubMed ID: 7534937
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
    Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
    Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein.
    Sedegah M; Kim Y; Peters B; McGrath S; Ganeshan H; Lejano J; Abot E; Banania G; Belmonte M; Sayo R; Farooq F; Doolan DL; Regis D; Tamminga C; Chuang I; Bruder JT; King CR; Ockenhouse CF; Faber B; Remarque E; Hollingdale MR; Richie TL; Sette A
    Malar J; 2010 Aug; 9():241. PubMed ID: 20735847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides.
    Widmann C; Romero P; Maryanski JL; Corradin G; Valmori D
    J Immunol Methods; 1992 Oct; 155(1):95-9. PubMed ID: 1383348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.